Biopharma Cred. Share News (BPCR)
BPCR Share
BPCR Share
BPCR Share
BPCR Share
BPCR
BPCR Share
BPCR Level 2
BPCR Live
BPCR Broker
BPCR Directors
BPCR Financial
BPCR
BPCR Short
BPCR
Last checked at -
To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.
Find out More
LONDON (Alliance News) - BioPharma Credit PLC said Friday it intends to raise USD150 million via share placing.The company will issue 146.3 million shares at USD1.025 per share, a 2.9% to a
Read moreLONDON (Alliance News) - BioPhamra Credit PLC on Thursday reported a sharp rise in income in the first halfIn the six months ended June, the life sciences debt investment trust increased to
Read moreLONDON (Alliance News) - BioPharma Credit PLC said Thursday that it has loaned USD150 million to Amicus Therapeutics Inc, a rare metabolic disease-focused biopharmaceutical company.Under in
Read moreLONDON (Alliance News) - BioPharma Credit PLC said Monday it has funded, alongside other investors, the USD200 million second tranche of a USD500 million loan to TESARO Inc.The company and
Read moreLONDON (Alliance News) - BioPharma Credit PLC said Friday Pablo Legorreta doubled his stake in the pharmaceutical debt investor in a transaction on Monday.Legorreta - the founder and chief
Read moreLONDON (Alliance News) - Life-science focused debt investor BioPharma Credit PLC said on Wednesday Pharmaceutical Investors LP sold shares in the company on Tuesday.After the transaction a
Read moreLONDON (Alliance News) - BioPharma Credit PLC said Tuesday that it has invested USD194 million in a unit of US-based Sebela Pharmaceuticals Inc.The life science-focused debt investor has a
Read moreLONDON (Alliance News) - Life science-focused debt investor BioPharma Credit PLC said on Monday it has become the lead investor and collateral agent for a USD315.0 million loan to an unnamed will
Read moreLONDON (Alliance News) - Life sciences debt investor BioPharma Credit PLC said Thursday it has had a "highly successful" 2017 and announced a share issue to raise on
Read more
Last checked at